FDA Updates Internal IDE Review Policy
This article was originally published in The Gray Sheet
Executive Summary
The new standard operating procedures will allow the recently established clinical trials director to get involved with resolving rejected investigational device exemptions or IDEs approved with conditions after the first round of FDA review.